Zealthy tirzepatide review
Advertised at $216 and billed at $216 — no gap. Position 7 of 18 on our board.
Updated 2026-09-18
DISCLOSURE — Coreage Rx pays this desk a commission when a reader signs up through our link. It buys no ranking, no score and no deletions. Method: how we rate. Full terms: disclosure.
About $216 a month, no membership renewing behind it, and a first-month rate that does not conceal a later charge. Nothing to report, which is the point.
Zealthy is one of a small group on this board where the quoted figure and the billed figure agree. From month two you pay roughly $216 and that is the whole charge.
The numbers
| Zealthy · tirzepatide | |
|---|---|
| Advertised | $216/mo |
| Membership | None |
| Billed | $216/mo |
| Advertised-to-billed gap | None |
| Per year | $2,592 |
| Board position | 7 of 18, cheapest first |
Compounded pricing quoted inclusive of the programme.
Where the gap is
One misleading figure floats around Zealthy’s marketing: $25 a month. That is an insured price for branded medication, not a cash price for the compounded product. Ignore it when comparing.
Against the board
About $2,592 a year, second cheapest on the tirzepatide board behind Coreage Rx.
| Programme | Advertised | Billed | Gap | Vs board floor |
|---|---|---|---|---|
| Coreage Rx | $149 | $199 | +$50 | +$74/mo |
| Trimi | $125 | $125 | none | — |
| Ozari Health | $125 | $125 | none | — |
| Fifty 410 | $133 | $133 | none | +$8/mo |
| PlexusDx | $129 | $189 | +$60 | +$64/mo |
| Ivím Health | $199 | $199 | none | +$74/mo |
| Zealthy | $216 | $216 | none | +$91/mo |
| Hims & Hers | $199 | $238 | +$39 | +$113/mo |
How the programme works
Broad telehealth platform with a weight programme that offers both compounded medication and insurance-billed branded prescriptions.
Verified facts
- First month advertised at $39.
- Compounded semaglutide priced from about $151/month.
- Compounded tirzepatide priced from about $216/month.
- Where insurance covers branded semaglutide, patient cost can fall to roughly $25/month.
Checked 2026-09-18. This market re-prices without notice — anything older than a month is a starting point, not a quote.
For it
- Compounded pricing is competitive without a separate membership charge.
- Will pursue insurance coverage rather than defaulting to cash pay.
- Low-friction $39 first month.
Against it
- The $25/month figure depends entirely on insurance approval and is not a cash price.
- Support is spread across a wide range of unrelated conditions.
Read this bit. The widely quoted $25/month is an insured price. Cash payers should plan on $151+ for semaglutide.
Score
3.5 out of 5 on our rubric, which is fixed before assessment and published on how we rate.
| Criterion | Weight | Score |
|---|---|---|
| True monthly cost | 30% | 3.8 / 5 |
| Price honesty | 20% | 3.5 / 5 |
| Clinical support | 20% | 3.4 / 5 |
| Pharmacy sourcing | 15% | 3.5 / 5 |
| Cancelling | 15% | 3.3 / 5 |
Verdict
Honest mid-market listing. Loses narrowly on price, loses on clinical depth to Mochi, and does not mislead you about either.
More from the desk
- Coreage Rx tirzepatide review
Advertised at $149, billed at $199. Position 1 of 18 on our board.
- Trimi tirzepatide review
Advertised at $125 and billed at $125 — no gap. Position 2 of 18 on our board.
- Ozari Health tirzepatide review
Advertised at $125 and billed at $125 — no gap. Position 3 of 18 on our board.
- Cheapest right now
Every programme sorted on what it bills, not what it advertises. Floor: $199/mo tirzepatide, $149/mo semaglutide.
- Six fee traps
Every advertised-to-billed gap on our board comes from one of these six structures. Learn them and you can read any of these sites in ninety seconds.
- Where the traps are
The biggest advertised-to-billed gaps on our board, and the programmes charging most for the same category of medication.